Atrial Fibrillation (AF) and Heart Failure With Preserved Ejection Fraction (HFpEF): Advances and Challenges
This state‐of‐the‐art review is based on the Philippe Coumel Lecture in 2024 (Figure 1). It highlights the confluence of two major cardiovascular epidemics, atrial fibrillation and heart failure, with preserved ejection fraction. In these conditions, advances in electrophysiology and heart failure physiology are intertwined and are integrated in this review. This constellation of disease states has its own unique epidemiologic features, pathophysiology, experimental and clinical mechanisms; and an increasing knowledge base with respect to clinical presentation, prognostic implications, and therapeutic options from pharmacologic advances and non‐pharmacologic interventions. Major advances, continuing challenges, and future directions in this condition are described in this rapidly evolving field of scientific endeavor.
No keywords indexed for this article. Browse by subject →
Margaret M. Redfield, Barry A. Borlaug
Paul A. Heidenreich, Nancy M. Albert, Larry A. Allen et al.
Gregory A. Roth, George A. Mensah, Catherine O. Johnson et al.
Gianluigi Savarese, Peter Moritz Becher, Lars H Lund et al.
Masaru Obokata, Thomas P Olson, Yogesh N V Reddy et al.
Biykem Bozkurt, Andrew J.S. COATS, Hiroyuki Tsutsui et al.
José A. Joglar, Mina K. Chung, Anastasia L. Armbruster et al.
Andreas Goette, Jonathan M. Kalman, Luis Aguinaga et al.
Showing 50 of 109 references
- Published
- Mar 10, 2025
- Vol/Issue
- 36(10)
- Pages
- 2720-2745
- License
- View
You May Also Like
FRANK CECCHIN, PATRICIA A. FRANGINI · 2008
257 citations
Wataru Shimizu, KIYOTAKA MATSUO · 2000
191 citations
Daniel Scherr, DARSHAN DALAL · 2009
155 citations
Mikhael F. El‐Chami, Jens Brock Johansen · 2019
127 citations